14 November 2020 - Late treatment study
Utility of Ivermectin and Doxycycline combination for the treatment of SARSCoV-2
et al., IAIM, 2020, 7:10, 177-182 (Peer Reviewed)
100 patient prospective trial of ivermectin + doxycycline showing reduced time to symptom resolution and shorter hospital stay with treatment.
|
recovery time, 21.1% lower, relative time 0.79, p = 0.03, treatment 50, control 50.
|
|
hospitalization time, 15.5% lower, relative time 0.84, p = 0.01, treatment 50, control 50.
|
| Effect extraction follows pre-specified rules prioritizing more serious outcomes. |
Spoorthi et al., 11/14/2020, prospective, India, South Asia, peer-reviewed, 2 authors, dosage not specified, this trial uses multiple treatments in the treatment arm (combined with doxycycline) - results of individual treatments may vary.
Please send us
corrections, updates, or comments. Vaccines and treatments are both
valuable and complementary. All practical, effective, and safe means
should be used. Elimination of COVID-19 is a race against viral evolution. No
treatment, vaccine, or intervention is 100% available and effective for all
current and future variants. Denying the efficacy of any method increases
mortality, morbidity, collateral damage, and the risk of endemic status. We do
not provide medical advice. Before taking any medication, consult a qualified
physician who can provide personalized advice and details of risks and
benefits based on your medical history and situation. WCH
and FLCCC provide
treatment protocols.